Nocion Therapeutics

Drug Discovery · Watertown, MA · Founded 2017 · Privately Held (backing)

Developer of a small molecule charged sodium channel designed to treat the conditions arising from neurogenic inflammation. Nocion Therapeutics is based in Watertown, MA and was founded in 2017. Its last reported valuation was $112 million in Aug 2021. It has raised $153 million across 3 recorded rounds; the latest was a $23 million early-stage round in Dec 2025.

Last reported valuation
$112.0M
Oct 2026
Priced at
—
Total raised
$153.0M
Last round
Early Stage VC
Dec 2025
What is Nocion Therapeutics worth?
$112.0Mlast reported valuation · Oct 2026

Nocion Therapeutics's last reported valuation, Aug 2021. Nothing priced has surfaced since.

Free account
More of Nocion Therapeutics with a free account
  • ·The complete investor list: 16 names
  • ·Watch Nocion Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Nocion Therapeutics funding history

3 rounds
DateRoundRaisedPost-money
Dec 2025Early Stage VC$23.0M▮
Feb 2024Early Stage VC$31.1M▮
Aug 2021Early Stage VC (Series A2)$7.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Nocion Therapeutics valuation

Nocion Therapeutics's last reported valuation was $112 million in Aug 2021. No priced round, secondary trade or fund mark has surfaced since.

How much has Nocion Therapeutics raised?

Nocion Therapeutics has raised $153 million in total; 3 of its rounds are on record, from 2021 on. The largest on record was a $7 million Series A2 in Aug 2021; the most recent was a $23 million early-stage round in Dec 2025.

Nocion Therapeutics has filed 5 Form Ds with the SEC since 2021, most recently in Mar 2026 ($23 million sold to 13 investors).

Comparable companies

Comparable drug discovery names by valuation on PrivateMarketView: Arsenal Medical ($124 million), Stylus Medicine ($114 million) and Kernalbio ($111 million).

How Nocion Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Nocion Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Nocion Therapeutics

What is Nocion Therapeutics worth?
Nocion Therapeutics is valued at $112.0M as of Oct 2026. Nocion Therapeutics's last reported valuation, Aug 2021. Nothing priced has surfaced since.
How much has Nocion Therapeutics raised?
Nocion Therapeutics has raised $153.0M in total funding across 3 recorded rounds.
When did Nocion Therapeutics last raise?
Nocion Therapeutics last raised in Dec 2025 (Early Stage VC), raising $23.0M.